Characterizing sexual function in patients with generalized anxiety disorder: a pooled analysis of three vilazodone studies

BACKGROUND: Vilazodone has been shown to reduce core symptoms of generalized anxiety disorder (GAD) in three randomized, double-blind, placebo-controlled trials. Since sexual dysfunction (SD) is not well characterized in GAD, a post hoc analysis of these trials was conducted to evaluate the effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Clayton, Anita H, Durgam, Suresh, Tang, Xiongwen, Chen, Changzheng, Ruth, Adam, Gommoll, Carl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4922821/
https://www.ncbi.nlm.nih.gov/pubmed/27382289
http://dx.doi.org/10.2147/NDT.S103408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4922821/
https://www.ncbi.nlm.nih.gov/pubmed/27382289
http://dx.doi.org/10.2147/NDT.S103408

Ejemplares similares